Clinical Trials Browser

OTHER × Interventional × Tuberous Sclerosis × Clear all

NCT06311474 2026-03-18

RAINBOW

Phase NA Completed

Mental Disorders, Tuberous Sclerosis

NCT06139172 2026-01-23

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

Phase NA Recruiting

Creatine deficiency, X-linked, Telomeric 22q13 Monosomy Syndrome, Chromosome 15q, partial deletion, Fragile X Syndrome, Hamartoma Syndrome, Multiple, Tuberous Sclerosis, Rett Syndrome, Angelman Syndrome

NCT05104983 2026-01-22

TSC-STEPS

Phase 2 Recruiting

Epilepsy, Tuberous Sclerosis

NCT05467397 2026-01-21

Feasibility of [11C]Acetate-PET in LAM and TSC

Phase 1/2 Active not recruiting

7 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT06879665 2025-09-22

TANDem-2

Phase NA Enrolling by invitation

Tuberous Sclerosis

NCT03836300 2025-07-31

Parent and Infant Inter(X)Action Intervention (PIXI)

Phase NA Enrolling by invitation

Telomeric 22q13 Monosomy Syndrome, Developmental Disabilities, DiGeorge Syndrome, Down Syndrome, Fragile X Syndrome, Klinefelter Syndrome, Prader-Willi Syndrome, Tuberous Sclerosis, Turner Syndrome, Rett Syndrome, Angelman Syndrome, Williams Syndrome, Muscular Dystrophy, Duchenne, Smith-Magenis Syndrome

NCT06081348 2025-07-16

CALM

Phase 2 Recruiting

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

NCT04698538 2024-10-30

TRAIN

Phase NA Completed

Tuberous Sclerosis

NCT02849457 2024-08-19

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

Phase 2 Completed

84 enrolled 16 charts

Tuberous Sclerosis

NCT04595513 2024-05-16

STOP2

Phase 1/2 Completed

5 enrolled 15 charts

Epilepsy, Tuberous Sclerosis

NCT05867576 2024-02-14

ACT in TSC

Phase NA Unknown

Psychological Well-Being, Tuberous Sclerosis

NCT04987463 2024-02-08

ViRap

Phase 2/3 Unknown

Epilepsy, Neoplasms, Tuberous Sclerosis

NCT04344626 2023-10-10

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Phase NA Withdrawn

Focal Cortical Dysplasia, Brain Neoplasms, Encephalitis, Epilepsy, Gliosis, Sturge-Weber Syndrome, Tuberous Sclerosis, Stroke, Hemimegalencephaly, Polymicrogyria

NCT05534672 2023-08-08

RaRE-TS

Phase 3 Recruiting

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

NCT00126672 2022-04-25

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Phase 2 Completed

36 enrolled 8 charts

Neoplasms, Tuberous Sclerosis, Angiomyolipoma

NCT02451696 2021-09-01

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

Phase 2 Completed

15 enrolled 9 charts

Focal Cortical Dysplasia, Epilepsy, Tuberous Sclerosis

NCT02860494 2021-05-03

EVEROST

Phase 2/3 Withdrawn

Tuberous Sclerosis

NCT01929642 2021-03-29

RAPT

Phase 2 Completed

3 enrolled 10 charts

Autistic Disorder, Tuberous Sclerosis, Self-Injurious Behavior

NCT03422367 2020-11-06

JETS

Phase NA Unknown

Autistic Disorder, Child Development Disorders, Pervasive, Epilepsy, Tuberous Sclerosis

NCT01526356 2020-10-26

Treatment

Phase 2 Completed

179 enrolled 13 charts

Tuberous Sclerosis, Angiofibroma

NCT02201212 2020-09-16

Everolimus for Cancer With TSC1 or TSC2 Mutation

Phase 2 Completed

30 enrolled 12 charts

Tuberous Sclerosis

NCT02061397 2020-08-25

SOS

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Phase 2 Unknown

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

NCT03326765 2018-10-17

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

Phase NA Unknown

Sleep Wake Disorders, Tuberous Sclerosis

NCT02687633 2018-05-02

Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex

Phase NA Completed

Tuberous Sclerosis

NCT03254680 2018-04-30

Turmeric as Treatment in Epilepsy

Phase NA Withdrawn

Epilepsy, Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT01954693 2018-01-30

TRON

Phase 2 Unknown

Tuberous Sclerosis

NCT01289912 2018-01-25

TSC

Phase 2 Completed

52 enrolled 12 charts

Autistic Disorder, Tuberous Sclerosis

NCT02104011 2018-01-23

STBETA

Phase 2 Completed

Tuberous Sclerosis

NCT01266291 2017-07-12

STARS

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

NCT03140449 2017-05-04

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

Phase 3 Completed

Tuberous Sclerosis

NCT01070316 2017-03-13

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

Phase 1/2 Completed

20 enrolled 8 charts

Epilepsy, Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis

NCT01853423 2016-08-19

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

Phase 1 Completed

Tuberous Sclerosis, Angiofibroma

NCT00989742 2015-12-02

Doxycycline In Lymphangioleiomyomatosis (LAM)

Phase 4 Completed

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT01730209 2015-05-05

RAPIT

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis

NCT00411619 2014-10-20

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Phase 1/2 Completed

28 enrolled 7 charts

Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis

NCT02098759 2014-04-04

EPISTOP

Phase NA Unknown

Epilepsy, Tuberous Sclerosis

NCT00457964 2013-09-25

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Phase 1/2 Completed

Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00792766 2013-09-18

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Phase 1/2 Completed

Tuberous Sclerosis, Angiolipoma

NCT01031901 2012-02-27

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Phase 1 Completed

Neurofibroma, Tuberous Sclerosis, Neurofibromatoses, Angiofibroma

NCT00490789 2008-04-30

TESSTAL

Phase 2 Unknown

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00457808 2007-04-09

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Phase 2 Completed

Tuberous Sclerosis, Lymphangioleiomyomatosis